Barriers to clinical implementation for novel therapies and biomarker testing in the community practice oncology setting: A CLDN18.2 case study
Purpose: Community-based practices often experience extended adoption times when implementing novel targeted agents, due to practical barriers. Delayed implementation of new therapies can potentially increase patient burden. This study aimed to objectively identify and quantify practice challenges t...
محفوظ في:
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Elsevier
2026-01-01
|
| سلاسل: | Cancer Treatment and Research Communications |
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://www.sciencedirect.com/science/article/pii/S2468294226001036 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|